Surgical infection prophylaxis for left ventricular assist device implantation

Journal of Cardiac Surgery

Volumn 26, Issue 4, 2011, Pages 440-443

  Walker, Paul C ^a   Depestel, Daryl D ^a,b   Miles, Nicholas A ^a   Malani, Preeti N ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b CUBIST PHARMACEUTICALS INC   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFUROXIME; CHLORHEXIDINE; CIPROFLOXACIN; FLUCONAZOLE; LEVOFLOXACIN; PIPERACILLIN; PSEUDOMONIC ACID; QUINOLONE; RIFAMPICIN; SULFAMETHOXAZOLE; TAZOBACTAM; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG USE; HEALTH CARE SURVEY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INSTITUTIONAL CARE; LEFT VENTRICULAR ASSIST DEVICE; MONOTHERAPY; PENICILLIN ALLERGY; POSTOPERATIVE CARE; SURGICAL INFECTION; SURGICAL INFECTION PROPHYLAXIS; TREATMENT RESPONSE;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; DRUG THERAPY, COMBINATION; HEALTH CARE SURVEYS; HEART-ASSIST DEVICES; HUMANS; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS;

EID: 79961026454     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2011.01262.x     Document Type: Article

References (8)

1. Rose EA, Gelijns AC, Moskowitz AJ, et al: Randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) study group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443.
2. Holman WL, Park SJ, Long JW, et al: Infection in permanent circulatory support: Experience from the REMATCH trial. J Heart Lung Transplant 2004; 23: 1359-1365. (Pubitemid 40018157)
3. Baddour LM, Bettmann MA, Bolger AF, et al: Nonvalvular cardiovascular device-related infections. Circulation 2003; 108: 2015-2031. (Pubitemid 37296549)
4. Edwards FH,: The society of thoracic surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, Part I: Duration. Ann Thorac Surg 2006; 81: 397-404. (Pubitemid 41815461)
5. Harbarth S, Samore MH, Lichtenberg D, et al,: Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916-2921. (Pubitemid 30415881)
6. Eyler RF, Butler SO, Walker PC, et al: Vancomycin use during left ventricular assist device support. Infect Control Hosp Epidemiol 2009; 30: 484-486.
7. Popovich KJ, Hota B, Hayes R, et al: Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009; 30: 959-963.
8. Munoz-Price LS, Hota B, Stemer A, et al: Prevention of bloodstream infection by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009; 30: 1031-1035.